CA
NZ
UK
AU
IND
US
Option Care Health (NASDAQ:OPCH) was one of the biggest gainers in the S&P MidCap 400 on Tuesday, October 6, 2026. The shares rocketed to around $31, after drug distributor McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to acquire the company for $32.05 a …
Option Care Health (NASDAQ:OPCH) rocketed on the S&P MidCap 400 on Tuesday, October 6, 2026, after McKesson (NYSE:MCK) and Clayton Dubilier & Rice agreed to take the company private. The buyers will pay $32.05 a share in cash, valuing the company at about $5.8 …
Revvity (NYSE:RVTY) slid on Tuesday, landing among the weaker members of the S&P 500 despite a fresh vote of confidence from Wall Street. William Blair initiated coverage of the company with an Outperform rating on the same day. No other company-specific catalyst was found …
Stryker (NYSE:SYK) slipped on Tuesday, trading around $280 during the session, after announcing aLeadershiptransition in a filing with the Securities and Exchange Commission dated October 6. Spencer Stiles, currently president and chief operating officer, will become chief executive on January 1, 2027. Kevin Lobo, …
Thermo Fisher Scientific (NYSE:TMO) edged lower on Tuesday, part of a broad pullback in life-science tools stocks within the S&P 500. No company announcement explaining the move was found. The decline mirrored moves at Danaher (NYSE:DHR), Agilent Technologies (NYSE:A), Revvity (NYSE:RVTY) and IQVIA (NYSE:IQV), …
Moderna (NASDAQ:MRNA) tumbled on Tuesday, closing at $187.46, as one of the steeper decliners in the S&P 500. Sources differed on the size of the drop, but all showed a sharp fall. The move was tied to profit-taking after the World Health Organization downgraded …
Illumina (NASDAQ:ILMN) slid on Tuesday, trading around $273.11 during the session, making it one of the more notable decliners in the S&P 500. The move followed a run that had carried the stock to a 52-week high. The drop was characterized as a technical …
IQVIA Holdings (NYSE:IQV) moved lower on Tuesday, falling alongside a cluster of life-science tools and services companies in the S&P 500. No company-specific news was found to explain the decline. Instead, the drug-development services and health-data company traded in line with peers that serve …
Danaher (NYSE:DHR) slipped on Tuesday, joining a broad retreat in life-science tools stocks across the S&P 500. No company announcement explaining the move was found. The conglomerate, which supplies equipment and consumables for biotechnology, life-science research and diagnostics, moved in step with its closest …
DexCom (NASDAQ:DXCM) fell on Tuesday, trading at about $83.39, with no specific catalyst identified for the move. The maker of continuous glucose monitors slid alongside a wide range of health-care stocks, a group that missed out on a broad rally that carried the S&P …
Please wait processing your request...